rs151001222

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_144991.3(TSPEAR):​c.170G>A​(p.Arg57Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000401 in 1,605,430 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R57W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0019 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 6 hom. )

Consequence

TSPEAR
NM_144991.3 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: 1.81

Publications

3 publications found
Variant links:
Genes affected
TSPEAR (HGNC:1268): (thrombospondin type laminin G domain and EAR repeats) This gene encodes a protein that contains a N-terminal thrombospondin-type laminin G domain and several tandem arranged epilepsy-associated repeats (EARs). A mutation in this gene is the cause of autosomal recessive deafness-98. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
TSPEAR Gene-Disease associations (from GenCC):
  • ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive nonsyndromic hearing loss 98
    Inheritance: AR Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015238225).
BP6
Variant 21-44567918-C-T is Benign according to our data. Variant chr21-44567918-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 227132.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00192 (292/152232) while in subpopulation AFR AF = 0.00643 (267/41538). AF 95% confidence interval is 0.00579. There are 1 homozygotes in GnomAd4. There are 142 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSPEARNM_144991.3 linkc.170G>A p.Arg57Gln missense_variant Exon 2 of 12 ENST00000323084.9 NP_659428.2 Q8WU66-1
TSPEARNM_001272037.2 linkc.-35G>A 5_prime_UTR_variant Exon 3 of 13 NP_001258966.1 Q8WU66

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSPEARENST00000323084.9 linkc.170G>A p.Arg57Gln missense_variant Exon 2 of 12 1 NM_144991.3 ENSP00000321987.4 Q8WU66-1
TSPEARENST00000397916.1 linkn.125G>A non_coding_transcript_exon_variant Exon 2 of 11 1
TSPEARENST00000642437.1 linkn.*115G>A non_coding_transcript_exon_variant Exon 3 of 13 ENSP00000496535.1 A0A2R8YFK6
TSPEARENST00000642437.1 linkn.*115G>A 3_prime_UTR_variant Exon 3 of 13 ENSP00000496535.1 A0A2R8YFK6

Frequencies

GnomAD3 genomes
AF:
0.00191
AC:
291
AN:
152114
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00642
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000786
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000545
AC:
134
AN:
245710
AF XY:
0.000444
show subpopulations
Gnomad AFR exome
AF:
0.00644
Gnomad AMR exome
AF:
0.000395
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000107
Gnomad OTH exome
AF:
0.000506
GnomAD4 exome
AF:
0.000242
AC:
351
AN:
1453198
Hom.:
6
Cov.:
30
AF XY:
0.000237
AC XY:
171
AN XY:
722466
show subpopulations
African (AFR)
AF:
0.00669
AC:
223
AN:
33312
American (AMR)
AF:
0.000433
AC:
19
AN:
43872
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25822
East Asian (EAS)
AF:
0.0000507
AC:
2
AN:
39476
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84918
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53220
Middle Eastern (MID)
AF:
0.00140
AC:
8
AN:
5726
European-Non Finnish (NFE)
AF:
0.0000596
AC:
66
AN:
1106848
Other (OTH)
AF:
0.000550
AC:
33
AN:
60004
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
19
38
58
77
96
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00192
AC:
292
AN:
152232
Hom.:
1
Cov.:
32
AF XY:
0.00191
AC XY:
142
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00643
AC:
267
AN:
41538
American (AMR)
AF:
0.000785
AC:
12
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68008
Other (OTH)
AF:
0.00190
AC:
4
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000550
Hom.:
0
Bravo
AF:
0.00220
ESP6500AA
AF:
0.00590
AC:
26
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000733
AC:
89
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Jun 01, 2016
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 22, 2019
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Apr 06, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.170G>A (p.R57Q) alteration is located in exon 2 (coding exon 2) of the TSPEAR gene. This alteration results from a G to A substitution at nucleotide position 170, causing the arginine (R) at amino acid position 57 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

TSPEAR-related disorder Benign:1
Jul 01, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arg57Gln in exon 2 of TSPEAR: This variant is not expected to have clinical sign ificance because it has been identified in 0.6% (26/4406) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs151001222). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.055
T;T
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.34
N
LIST_S2
Benign
0.75
.;T
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.015
T;T
MetaSVM
Benign
-0.82
T
MutationAssessor
Uncertain
2.8
M;M
PhyloP100
1.8
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.2
.;N
REVEL
Benign
0.16
Sift
Benign
0.16
.;T
Sift4G
Uncertain
0.015
D;D
Polyphen
0.98
D;D
Vest4
0.26
MVP
0.040
MPC
0.056
ClinPred
0.016
T
GERP RS
2.8
Varity_R
0.072
gMVP
0.51
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151001222; hg19: chr21-45987802; COSMIC: COSV59959974; API